The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Functional profile and clinical significance of major tumor infiltrating lymphocyte subsets in lung cancer-associated brain metastases.
 
Benjamin Y. Lu
Stock and Other Ownership Interests - Gilead Sciences; Pfizer
 
Richa Gupta
No Relationships to Disclose
 
Tyler Stewart
No Relationships to Disclose
 
Harriet M. Kluger
Consulting or Advisory Role - Biodesix; Celldex; Corvus Pharmaceuticals; Genentech/Roche; Immunocore; Iovance Biotherapeutics; Merck; Nektar; Pfizer
Research Funding - Apexigen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Apexigen
 
Lucia Jilaveanu
No Relationships to Disclose
 
Kurt A. Schalper
Honoraria - Fluidigm; Merck; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Celgene; Pierre Fabre; Shattuck Labs
Research Funding - Bristol-Myers Squibb; Merck; Moderna Therapeutics; Navigate BioPharma; Onkaido Therapeutics; Pierre Fabre; Surface Oncology; Takeda; Tesaro; Vasculox
 
Sarah B. Goldberg
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Spectrum Pharmaceuticals
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech (Inst); Immunogen (Inst); Kadmon (Inst); Merck (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)